MENU
KNSA
AS OF
Feb 4, 04:46 PM (EDT)
Price
$43.79
Change
-$1.17 (-2.60%)
Capitalization
3.41B
27 days until earnings call
Intraday BUY SELL Signals
+Compare
KNSA
Stock ticker: NASDAQ
AS OF
Feb 4, 04:46 PM (EDT)
Price
$43.79
Change
-$1.17 (-2.60%)
Capitalization
3.41B

KNSA Kiniksa Pharmaceuticals International plc Forecast, Technical & Fundamental Analysis

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

KNSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KNSA with price predictions
Feb 03, 2026

KNSA in upward trend: price rose above 50-day moving average on January 21, 2026

KNSA moved above its 50-day moving average on January 21, 2026 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 22, 2026. You may want to consider a long position or call options on KNSA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KNSA just turned positive on January 22, 2026. Looking at past instances where KNSA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for KNSA crossed bullishly above the 50-day moving average on January 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

KNSA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KNSA entered a downward trend on January 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KNSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.369) is normal, around the industry mean (29.792). P/E Ratio (99.978) is within average values for comparable stocks, (74.095). KNSA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). KNSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (5.764) is also within normal values, averaging (116.680).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
KNSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KNSA is expected to report earnings to rise 50.87% to 34 cents per share on March 03

Kiniksa Pharmaceuticals International plc KNSA Stock Earnings Reports
Q4'25
Est.
$0.35
Q3'25
Missed
by $0.09
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.14
The last earnings report on October 28 showed earnings per share of 23 cents, missing the estimate of 31 cents. With 50.43K shares outstanding, the current market capitalization sits at 3.41B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSMCX37.040.35
+0.95%
Goldman Sachs Mid Cap Value Instl
CSMUX25.700.23
+0.90%
Carillon Scout Mid Cap R-6
RGGHX41.21-0.06
-0.15%
American Funds Global Balanced R2E
LGCCX20.19-0.09
-0.44%
Lord Abbett Global Equity C
NIAGX14.40-0.11
-0.76%
Nia Impact Solutions

KNSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.65%
COYA - KNSA
42%
Loosely correlated
+2.53%
ABVC - KNSA
40%
Loosely correlated
+0.53%
JBIO - KNSA
37%
Loosely correlated
+2.28%
AMRN - KNSA
36%
Loosely correlated
+0.37%
CPRX - KNSA
36%
Loosely correlated
+0.88%
More

Groups containing KNSA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.65%
Pharmaceuticals
category (380 stocks)
26%
Poorly correlated
-0.30%
Pharmaceuticals: Generic
category (214 stocks)
12%
Poorly correlated
-0.59%